Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer
<p>Abstract</p> <p>Background</p> <p>Most bladder cancer patients experience lymphatic metastasis in the course of disease progression, yet the relationship between lymphangiogenesis and lymphatic metastasis is not well known. The aim of this study is to elucidate under...
Main Authors: | Kim Wun-Jae, Kim Injune, Heston Warren, Alitalo Kari, Schwendener Reto A, Kim Min-Ju, Kim Chan, Yang Hanseul, Koh Gou |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/36 |
Similar Items
-
Lymphangiogenesis and lymphatic metastasis in human breast cancer
by: Cunnick, Giles Harvey
Published: (2002) -
Lymphatics and Lymphangiogenesis in the Eye
by: Shintaro Nakao, et al.
Published: (2012-01-01) -
Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells
by: Huai-Ching Tai, et al.
Published: (2019-04-01) -
Pannexin-1 in Human Lymphatic Endothelial Cells Regulates Lymphangiogenesis
by: Jonathan Boucher, et al.
Published: (2018-05-01) -
Fucoidan Suppresses Hypoxia-Induced Lymphangiogenesis and Lymphatic Metastasis in Mouse Hepatocarcinoma
by: Hongming Teng, et al.
Published: (2015-06-01)